Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Stephane Paul"'
Autor:
Parveen Sobia, Sharana Mahomed, Aida Sivro, Stephane Paul, Farzana Osman, Ishana Harkoo, Nigel Garrett, Quarraisha Abdool Karim, Salim S. Abdool Karim, Derseree Archary
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Acute, transient lymphocytopenia, not clinically significant was observed in the CAPRISA 012B phase 1 clinical trial following administration of broadly neutralizing antibodies (bnAb)-CAP256V2LS alone or with VRC07-523LS. Lymphocytopenia was
Externí odkaz:
https://doaj.org/article/e5979693daf14179af63a736438522fe
Autor:
Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, Nesrine Mabrouk, Gauthier Gadouas, Corinne Desaint, Lucie Chevrier, Maeva Lefebvre, Anne Radenne, Marie Roelens, Béatrice Parfait, Daniela Weiskopf, Alessandro Sette, Nadège Gruel, Marie Courbebaisse, Victor Appay, Stephane Paul, Guy Gorochov, Jacques Ropers, Said Lebbah, Jean-Daniel Lelievre, Ludger Johannes, Jonathan Ulmer, David Lebeaux, Gerard Friedlander, Xavier De Lamballerie, Patrice Ravel, Marie Paule Kieny, Fréderic Batteux, Christine Durier, Odile Launay, Eric Tartour
Publikováno v:
iScience, Vol 27, Iss 8, Pp 110441- (2024)
Summary: Coordinating immune responses – humoral and cellular – is vital for protection against severe Covid-19. Our study evaluates a multicytokine CD4+T cell signature’s predictive for post-vaccinal serological and CD8+T cell responses. A cyt
Externí odkaz:
https://doaj.org/article/bae9b74a735344409d5106899f8ed864
Autor:
Stephanie Longet, Stephane Paul
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/e28774e67a884f3c818333e0f08900ed
Autor:
Sodiq A. Hameed, Stephane Paul, Giann Kerwin Y. Dellosa, Dolores Jaraquemada, Muhammad Bashir Bello
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-20 (2022)
Abstract The mRNA vaccine platform has offered the greatest potential in fighting the COVID-19 pandemic owing to rapid development, effectiveness, and scalability to meet the global demand. There are many other mRNA vaccines currently being developed
Externí odkaz:
https://doaj.org/article/c3f0e4dd70c24a9e8e67b2df04ec09ce
Publikováno v:
BMC Immunology, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background ABP501 is a biosimilar to Reference Adalimumab (HUMIRA®) produced by AMGEN. Adalimumab (ADA) has a marketing authorization for Crohn's disease, ulcerative colitis and other inflammatory or autoimmune diseases. The aim of this stu
Externí odkaz:
https://doaj.org/article/c3708cef279948d4815a4e5cf5ac37fd
Autor:
Robin Caire, Estelle Audoux, Guillaume Courbon, Eva Michaud, Claudie Petit, Elisa Dalix, Marwa Chafchafi, Mireille Thomas, Arnaud Vanden-Bossche, Laurent Navarro, Marie-Thérèse Linossier, Sylvie Peyroche, Alain Guignandon, Laurence Vico, Stephane Paul, Hubert Marotte
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveThe role of YAP/TAZ, two transcriptional co-activators involved in several cancers, was investigated in rheumatoid arthritis (RA).MethodsFibroblast like synoviocytes (FLS) from patients with RA or osteoarthritis were cultured in 2D or into 3
Externí odkaz:
https://doaj.org/article/c8a7be7d59f641a9ade0135792c1b72b
Autor:
Anne Emmanuelle Berger, Aude Gleizes, Louis Waeckel, Xavier Roblin, Roman Krzysiek, Salima Hacein-Bey-Abina, Alessandra Soriano, Stephane Paul
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 17, p 9561 (2022)
Background. Monitoring of biological TNF inhibitors is a very important tool to guide clinical decisions using specialized algorithms, especially in gastroenterology. A new chemiluminescent instrument (i-TRACK10® from Theradiag) could replace ELISA
Externí odkaz:
https://doaj.org/article/88082a09d693401a8874c1210f106644
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 10 (2017)
Golimumab (GLM) is the latest anti-tumor necrosis factor (TNF) that gained its marketing license. Thanks to the PURSUIT induction and maintenance trials, it was approved for the treatment of ulcerative colitis (UC) in 2013. The other anti-TNF drugs a
Externí odkaz:
https://doaj.org/article/a6308d1e8b2242d599f849a252d19753
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119844 (2015)
Neutrophils contribute to pathogen clearance through pattern recognition receptors (PRRs) activation. However, the role of PRRs in neutrophils in both HIV-1-infected [HIV-1(+)] and HIV-1-exposed seronegative individuals (HESN) is unknown. Here, a stu
Externí odkaz:
https://doaj.org/article/200a8e35d7ec4dff9ac619869e96c0a2
Autor:
Federica Capanna, Stephane Paul Emonet, Abdessalam Cherkaoui, Olivier Patrick Irion, Jacques Schrenzel, Begoña Martinez de Tejada
Publikováno v:
Swiss Medical Weekly, Vol 143, Iss 1314 (2013)
STUDY/PRINCIPLES: Antibiotic prophylaxis of Group B Streptococcus (GBS) positive women during labour reduces the risk of early-onset neonatal sepsis. Penicillin is the first choice, and clindamycin and erythromycin are second choices for penicillin-a
Externí odkaz:
https://doaj.org/article/0344eed40f244b0d8ac03b6603baee93